Next Article in Journal
Sacral insufficiency fracture after pelvic radiotherapy: A diagnostic challenge for a radiologist
Previous Article in Journal
Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessCase Report

Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx

1
Department of Radiation Oncology, National Cancer Institute, Vilnius, Lithuania
2
Department of Radiation Oncology, Clinique et Maternité Sainte-Elisabeth, Namur, Belgium
3
Radiotherapy and Drug Therapy Centre, National Cancer Institute, Vilnius, Lithuania
4
Faculty of Medicine, Vilnius University, Vilnius, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2014, 50(4), 245-248; https://doi.org/10.1016/j.medici.2014.09.003
Received: 16 May 2014 / Accepted: 15 September 2014 / Published: 29 September 2014
Cetuximab (CTX) is used for the concurrent treatment with radiotherapy (RT) in squamous cell carcinoma of head and neck (HNSCC). There are no reliable clinical predictive markers of effectiveness of CTX at yet. We describe the clinical case of patient who received a CTX/RT to cure locoregionally advanced hypopharyngeal SCC. 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography and computed tomography (18FDG-PET/CT) was performed before the treatment and repeated 10 days after CTX induction dose. A repeated 18FDGPET/ CT scan showed dramatic decrease of metabolic parameters. Patient had a complete response after treatment and is still alive and cured after 5 years.
Keywords: Cetuximab; Head and neck cancer; Predictive marker; FDG-PET/CT; Radiotherapy Cetuximab; Head and neck cancer; Predictive marker; FDG-PET/CT; Radiotherapy
MDPI and ACS Style

Grybauskas, M.; Daisne, J.-F.; Aleknavičius, E.; Burneckis, A. Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx. Medicina 2014, 50, 245-248.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop